Pharmaceutical company Durect has struck a deal with Venrock to sell 4.4 million shares of common stock at $2.25 each (a 9 percent discount) to raise $10 million more. Based in Cupertino, Calif., the company, recently valued at $215 million, says it will use the funds for general working capital and... (Read more)
Reprinted with permission from
VentureBeat. Story copyright 2009 VentureBeat Inc. All rights reserved.
Post new comment